NOAEL Studies
Cosmetic Ingredient
HC Red No. 3 NOAEL Studies
INCI: HC RED NO. 3
CAS: 2871-01-4
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 15 | mg/kg bw/day | mouse | oral | 13 week | Subchronic | SCCS; Toxicology and Carcinogenesis Studies of HC Red No. 3 in F344/N Rats and B6C3F1Mice (Gavage Studies), National Toxicology Program, Technical Report Series No. 281,January 1986, DHHS |
IARC Monographs 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| IARC Monographs | IARC carcinogenicity classification | 3 | IARC group | - | - | 1992 | IARC Monographs | - |
NTP ICE acute oral 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP ICE acute oral | LD50 | >1000 | mg/kg bw | Rat | oral | acute | Rat Acute Oral Toxicity | record_id=acute_oral_5033; row=3909; data_type=In Vivo; mixture=Chemical; chemical_name=HC Red 3; preferred_name=HC Red 3; dtxsid=DTXSID2021236; url_comptox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2021236; url_cebs=https://doi.org/10.22427/NTP-DATA-DTXSID2021236; source_file=acute_oral.xlsx |
NTP ICE cancer 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP ICE cancer | IARC group | 3 | unitless | - | - | - | WOE; IARC Carcinogenicity | sheet=Data; excel_row=2609; Record_ID=cancer_34; Data_Type=WOE; Formulation_Name=HC Red 3; Mixture=Chemical; DTXSID=DTXSID2021236; Assay=IARC Carcinogenicity; Endpoint=IARC group; Response=3; Response_Unit=Unitless; URL=http://publications.iarc.fr/75; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2021236; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID2021236 |
| NTP ICE cancer | Top dose | 250 | mg/kg bw/day | Mouse | Gavage | - | In Vivo; NTP Carcinogenicity | sheet=Data; excel_row=2606; Record_ID=cancer_32; Data_Type=In Vivo; Formulation_Name=HC Red 3; Mixture=Chemical; DTXSID=DTXSID2021236; Assay=NTP Carcinogenicity; Endpoint=Top dose; Response=250; Response_Unit=mg/kg/day; Species=Mouse; Strain=B6C3F1; Sex=Male; Route=Gavage; Reference=TR-281; URL=https://ntp.niehs.nih.gov/publications/reports/tr/200s/tr281/index.html; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2021236; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID2021236 |
| NTP ICE cancer | Top dose | 500 | mg/kg bw/day | Rat | Gavage | - | In Vivo; NTP Carcinogenicity | sheet=Data; excel_row=2611; Record_ID=cancer_37; Data_Type=In Vivo; Formulation_Name=HC Red 3; Mixture=Chemical; DTXSID=DTXSID2021236; Assay=NTP Carcinogenicity; Endpoint=Top dose; Response=500; Response_Unit=mg/kg/day; Species=Rat; Strain=F344/N; Sex=Female; Route=Gavage; Reference=TR-281; URL=https://ntp.niehs.nih.gov/publications/reports/tr/200s/tr281/index.html; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2021236; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID2021236 |
NTP ICE skin sensitization 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP ICE skin sensitization | EC3 | 2.2 | % | Mouse | Dermal | - | In Vivo; LLNAdb2013; LLNA | sheet=Data_invivo; excel_row=13175; Record_ID=skin_sensitization_invivo_3200; Data_Type=In Vivo; Internal_Data_Source=LLNAdb2013; Mixture=Chemical; DTXSID=DTXSID2021236; Assay=LLNA; Endpoint=EC3; Response=2.2; Response_Unit=%; Species=Mouse; Route=Dermal; Reference=Gerberick et al. 2005; 16536334; Not available; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID2021236; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID2021236 |
SCCS Opinion 16 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.003 | mg/kg bw | mouse | oral | 90-day | dermal absorption | p.48 |
| SCCS Opinion | NOAEL | =0.01 | mg/kg bw | mouse | oral | 90-day | dermal absorption | p.45 |
| SCCS Opinion | NOAEL | =0.015 | mg/kg bw | mouse | oral | 90-day | dermal absorption | p.48 |
| SCCS Opinion | NOAEL | =0.02 | % | mouse | oral | Chronic | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =45 | mg/kg bw/d | mouse | oral | 90-day | dermal absorption | p.48 |
| SCCS Opinion | NOAEL | =50 | % | mouse | oral | 90-day | dermal absorption | p.48 |
| SCCS Opinion | NOAEL | =90 | mg/kg bw/d | mouse | oral | 90-day | dermal absorption | p.45 |
| SCCS Opinion | NOAEL | =97.5 | - | - | - | - | NOAEL study | p.44 |
| SCCS Opinion | NOAEL | =125 | mg/kg bw/d | rat | - | 5 days | NOAEL study | p.21 |
| SCCS Opinion | NOAEL | =200 | mg/kg/d | rabbit | oral | developmental | developmental toxicity | p.43 |
| SCCS Opinion | NOAEL | =200 | mg/kg bw/d | rabbit | oral | developmental | developmental toxicity | p.45 |
| SCCS Opinion | NOAEL | =250 | mg/kg bw/d | rat | oral | 5 days | NOAEL study | p.21 |
| SCCS Opinion | NOAEL | =500 | mg/kg bw/d | rat | oral | 14-day | repeated dose toxicity | p.20 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/d | rat | oral | 14-day | repeated dose toxicity | p.20 |
| SCCS Opinion | NOAEL | =1000 | mg/kg/d | rabbit | oral | developmental | developmental toxicity | p.43 |
| SCCS Opinion | NOAEL | =7800 | ppm | - | - | 13 days | reproductive toxicity | p.41 |
ECHA 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ECHA | NOAEL | =200 | mg/kg bw/day | Rat | oral | - | reproduction developmental | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eac1ae4b0a7c65d1bd5a2; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/22771/7/9/3?documentUUID=2ac25915-d18c-4c07-82b1-eed21940e2da; YEAR=2000; ORIGINAL_YEAR=2000; TOXICOLOGICAL_EFFECT=maternal: body weight and weight gain|maternal: clinical signs; TOXICOLOGICAL_EFFECT_CATEGORY=body weight|clinical signs; STUDY_GROUP=ECHA IUCLID_dup_Developmental Toxicity Teratogenicity_15823058_15824717:F:-maternal; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_11b3a43756889e85f14d9dd54e56dbc6 |
| ECHA | NOAEL | >250 | mg/kg bw/day | Mouse | oral | subchronic; 13 weeks | subchronic | QUALITY=2 (reliable with restrictions); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eae06e4b0a7c65d1c71e2; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/22771/7/6/2?documentUUID=2ac25915-d18c-4c07-82b1-eed21940e2da; YEAR=2000; ORIGINAL_YEAR=2000; TOXICOLOGICAL_EFFECT=body weight and weight gain|clinical signs|gross pathology|histopathology: non-neoplastic; TOXICOLOGICAL_EFFECT_CATEGORY=body weight|clinical signs|gross pathology|nonneoplastic histopathology; STUDY_GROUP=ECHA IUCLID:15849377:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, and this record was expert reviewed; QC_STATUS=pass; SOURCE_HASH=ToxValhc_d27ba623329de4eb9d85f97dfb7aa9b3 |
| ECHA | NOAEL | >500 | mg/kg bw/day | Mouse | oral | short-term; 14 days | short-term | QUALITY=2 (reliable with restrictions); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/66a7cb04e4b0a7c65d2248ba; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/22771/7/6/2?documentUUID=2ac25915-d18c-4c07-82b1-eed21940e2da; YEAR=2000; ORIGINAL_YEAR=2000; TOXICOLOGICAL_EFFECT=clinical signs|gross pathology|mortality; TOXICOLOGICAL_EFFECT_CATEGORY=clinical signs|gross pathology|mortality/survival; STUDY_GROUP=ECHA IUCLID:15849375:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, and this record was expert reviewed; QC_STATUS=pass; SOURCE_HASH=ToxValhc_648207453de897c2994217d326904565 |
| ECHA | NOAEL | =1000 | mg/kg bw/day | Rat | oral | - | reproduction developmental | QUALITY=2 (reliable with restrictions); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eac1ae4b0a7c65d1bd59a; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/22771/7/9/3?documentUUID=2ac25915-d18c-4c07-82b1-eed21940e2da; YEAR=2000; ORIGINAL_YEAR=2000; STUDY_GROUP=ECHA IUCLID_dup_Developmental Toxicity Teratogenicity_15823058_15824717:F:-maternal; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, and this record was expert reviewed; QC_STATUS=pass; SOURCE_HASH=ToxValhc_222d0559cef807d44d496b09b41ed244 |
Regulatory source 23 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 0.02 | % | mouse | oral | Chronic | - | p.22 |
| Regulatory source | - | 97.5 | - | - | - | - | - | p.44 |
| Regulatory source | - | 125 | mg/kg bw/d | rat | - | 5 days | - | p.21 |
| Regulatory source | - | 250 | mg/kg bw/d | rat | oral | 5 days | - | p.21 |
| Regulatory source | - | 250 | mg/kg bw/d | rat | - | 5 days | - | p.21 |
| Regulatory source | dermal absorption | =0.003 | mg/kg bw | mouse | oral | 90-day | dermal absorption | p.48 |
| Regulatory source | dermal absorption | =0.01 | mg/kg bw | mouse | oral | 90-day | dermal absorption | p.45 |
| Regulatory source | dermal absorption | =0.015 | mg/kg bw | mouse | oral | 90-day | dermal absorption | p.48 |
| Regulatory source | dermal absorption | =45 | mg/kg bw/d | mouse | oral | 90-day | dermal absorption | p.48 |
| Regulatory source | dermal absorption | 50 | % | mouse | oral | 90-day | dermal absorption | p.48 |
| Regulatory source | dermal absorption | =90 | mg/kg bw/d | mouse | oral | 90-day | dermal absorption | p.45 |
| Regulatory source | developmental toxicity | 200 | mg/kg/d | rabbit | oral | developmental | developmental toxicity | p.43 |
| Regulatory source | developmental toxicity | 200 | mg/kg/d | rat | oral | developmental | developmental toxicity | p.46 |
| Regulatory source | developmental toxicity | 200 | mg/kg bw/d | rabbit | oral | developmental | developmental toxicity | p.45 |
| Regulatory source | developmental toxicity | 200 | mg/kg bw/d | rat | oral | developmental | developmental toxicity | p.49 |
| Regulatory source | developmental toxicity | 1000 | mg/kg/d | rabbit | oral | developmental | developmental toxicity | p.43 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw/d | rat | oral | 5 days | developmental toxicity | p.46 |
| Regulatory source | developmental toxicity | 1000 | mg/kg/d | rat | oral | developmental | developmental toxicity | p.46 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw/d | rabbit | oral | developmental | developmental toxicity | p.45 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw/d | rat | oral | developmental | developmental toxicity | p.49 |
| Regulatory source | repeated dose toxicity | 500 | mg/kg bw/d | rat | oral | 14-day | repeated dose toxicity | p.20 |
| Regulatory source | repeated dose toxicity | 1000 | mg/kg bw/d | rat | oral | 14-day | repeated dose toxicity | p.20 |
| Regulatory source | reproductive toxicity | 7800 | ppm | - | - | 13 days | reproductive toxicity | p.41 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 51CPX7M1SQ | UNII | - | - | - | chemical | - |